Targeting hyponitroxia in cancer therapy

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

It was Oscar Wilde who said "nothing succeeds like excess." Tumors, in particular, subscribe to this creed of greed, avidly consuming glucose, glutamine and lipids while simultaneously overexpressing and stimulating signal transduction pathways in order to accelerate the rate of proliferation and progression. Nitricoxide (NO) is the rare exception to the success of excess in tumors since, in this case, less is more: at low "hyponitroxic" levels NO promotes proliferation while athigh levels NO suppresses it.

Author supplied keywords

Cite

CITATION STYLE

APA

Oronsky, B., Oronsky, N., Lybeck, M., Fanger, G., & Scicinski, J. (2015). Targeting hyponitroxia in cancer therapy. In Nitric Oxide and Cancer: Pathogenesis and Therapy (pp. 39–48). Springer International Publishing. https://doi.org/10.1007/978-3-319-13611-0_3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free